Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sertraline-induced hypoglycemia.

P T Pollak1, S D Mukherjee, A D Fraser

  • 1Department of Medicine, College of Pharmacy, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. amiokinectics@hotmail.com

The Annals of Pharmacotherapy
|November 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Code status communication training in postgraduate oncology programs: a needs assessment.

Current oncology (Toronto, Ont.)·2020
Same author

Implementing changes to a residency program curriculum before competency-based medical education: a survey of Canadian medical oncology program directors.

Current oncology (Toronto, Ont.)·2020
Same author

Improving formative assessments in Canadian medical oncology residency training.

Current oncology (Toronto, Ont.)·2020
Same author

An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.

Current oncology (Toronto, Ont.)·2019
Same author

Surgical attitudes toward preoperative breast magnetic resonance imaging in women with early-stage breast cancer.

Current oncology (Toronto, Ont.)·2019
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Selective serotonin-reuptake inhibitors like sertraline may cause hypoglycemia. An 82-year-old patient experienced recurrent hypoglycemia after starting sertraline, which resolved upon discontinuation, highlighting a potential drug-induced adverse effect.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Clinical Medicine

Background:

  • Selective serotonin-reuptake inhibitors (SSRIs) are commonly prescribed for depression.
  • Hypoglycemia is a serious condition characterized by abnormally low blood glucose levels.

Observation:

  • An 82-year-old non-diabetic female presented with recurrent presyncopal episodes and severe hypoglycemia (32 mg/dL).
  • The patient had recently initiated sertraline 50 mg daily for mild depression.
  • Despite glucose administration, hypoglycemia persisted until sertraline was discontinued.

Findings:

  • Serum sertraline and desmethylsertraline levels showed a prolonged half-life, consistent with the clinical presentation.
  • This case suggests sertraline may independently cause hypoglycemia in non-diabetic individuals.

Related Experiment Videos

  • The patient experienced resolution of hypoglycemia after sertraline cessation.

    • Implications:

    • Healthcare providers should consider SSRIs, including sertraline, as a potential cause of hypoglycemia.
    • Further investigation into the mechanism of SSRI-induced hypoglycemia is warranted.
    • This finding is supported by another case implicating fluoxetine, another SSRI.